239 related articles for article (PubMed ID: 15492782)
1. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality.
Ito R; Nakayama H; Yoshida K; Oda N; Yasui W
Oncol Rep; 2004 Nov; 12(5):985-90. PubMed ID: 15492782
[TBL] [Abstract][Full Text] [Related]
2. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.
Ogasawara S; Maesawa C; Yamamoto M; Akiyama Y; Wada K; Fujisawa K; Higuchi T; Tomisawa Y; Sato N; Endo S; Saito K; Masuda T
Oncogene; 2004 Feb; 23(5):1117-24. PubMed ID: 14743202
[TBL] [Abstract][Full Text] [Related]
3. Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines.
Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Kuroda M; Nagai N; Yanagi Y; Inoue T; Kawasaki S; Tanaka N; Matsubara N; Kishi K
Oral Oncol; 2004 Jul; 40(6):597-603. PubMed ID: 15063388
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
5. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells.
Akiyama Y; Maesawa C; Ogasawara S; Terashima M; Masuda T
Am J Pathol; 2003 Nov; 163(5):1911-9. PubMed ID: 14578190
[TBL] [Abstract][Full Text] [Related]
6. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
[TBL] [Abstract][Full Text] [Related]
7. Expression and regulation of tumor suppressor gene maspin in breast cancer.
Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
[TBL] [Abstract][Full Text] [Related]
8. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
Kim S; Han J; Kim J; Park C
Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
[TBL] [Abstract][Full Text] [Related]
9. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.
Bettstetter M; Woenckhaus M; Wild PJ; Rümmele P; Blaszyk H; Hartmann A; Hofstädter F; Dietmaier W
J Pathol; 2005 Apr; 205(5):606-14. PubMed ID: 15714592
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
[TBL] [Abstract][Full Text] [Related]
11. Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis.
Boltze C
Pathol Res Pract; 2005; 200(11-12):783-90. PubMed ID: 15792121
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer.
Chen W; Gao N; Shen Y; Cen JN
J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341
[TBL] [Abstract][Full Text] [Related]
14. Maspin and p53 protein expression in gastric adenocarcinoma and its clinical applications.
Lee DY; Park CS; Kim HS; Kim JY; Kim YC; Lee S
Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):13-8. PubMed ID: 18091326
[TBL] [Abstract][Full Text] [Related]
15. Effects of shRNA targeting maspin on invasion of gastric carcinoma SGC7901 cell line.
Yang Y; Shi H; Li X; Yi Y
Oncol Rep; 2011 Jan; 25(1):259-65. PubMed ID: 21109985
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of maspin expression in human ovarian carcinoma cells.
Rose SL; Fitzgerald MP; White NO; Hitchler MJ; Futscher BW; De Geest K; Domann FE
Gynecol Oncol; 2006 Aug; 102(2):319-24. PubMed ID: 16457875
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclin-dependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity.
Yasui W; Akama Y; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
J Pathol; 1996 Oct; 180(2):122-8. PubMed ID: 8976868
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
[TBL] [Abstract][Full Text] [Related]
19. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
Duan H; Zhang HJ; Yang JQ; Oberley LW; Futscher BW; Domann FE
Antioxid Redox Signal; 2003 Oct; 5(5):677-88. PubMed ID: 14580325
[TBL] [Abstract][Full Text] [Related]
20. [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma].
He Y; Zhang L; Li YJ; Ye F; Jiang Y; Jin XM
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(13):909-12. PubMed ID: 17650404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]